检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:余毅[1] 王琰 黄继义[1] YU Yi;WANG Yan;HUANG Ji-yi(Department of Nephrology,The First Affiliated Hospital Xiang'an District,Xiamen University,Fuzhou 361101,China;Department of Nephrology,The Mengchao Hepatobiliary Hospital,Fujian Medical University,Fuzhou 350025,China)
机构地区:[1]厦门大学附属第一医院翔安院区肾内科,福州361101 [2]福建医科大学孟超肝胆医院肾内科,福州350025
出 处:《中国血液净化》2021年第12期801-804,共4页Chinese Journal of Blood Purification
摘 要:连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)主要原理是利用超滤作用清除体内过多的水分,以对流的方式清除中、小分子溶质,利用吸附清除炎症介质。在临床应用中,不断衍生出各种治疗模式:连续性静静脉血液滤过(continuous venous-venous hemofiltration,CVVH)、连续性静静脉血液透析滤过(continuous venous-venous hemodiafiltration,CVVHDF)、高容量血液滤过(high-volume hemofiltration,HVHF)、连续性血浆滤过吸附(continuous plasma filtration adsorption,CPFA)、缓慢连续性超滤(slow continuous ultrafiltration,SCUF)、持续低流量血液透析(sustained lowefficiency dialysis,SLED)等等。CVVH是临床最常用的治疗模式,常用于顽固性心力衰竭、重症急性胰腺炎、横纹肌溶解等的辅助治疗;CVVHDF近年广泛应用于脓毒血症的治疗,HVHF常用于重症脓毒血症、感染性休克的患者;CPFA可用于重度炎症反应综合征和脓毒血症;SCUF常用于难治性心力衰竭、水肿,细胞外液容量高负荷者。目前常用的CRRT技术各有其自身特点,可根据病情需要个体化合理选择治疗模式和治疗剂量。Continuous renal replacement therapy(CRRT)has the roles of ultrafiltration to remove excess water,convection to clear medium and small molecular solutes,and adsorption to eliminate inflammatory mediators.The therapeutic models of CRRT are developed progressively,such as continuous venous-venous hemofiltration(CVVH),continuous venous-venous hemodiafiltration(CVVHDF),high-volume hemofiltration(HVHF),continuous plasma filtration adsorption(CPFA),and slow continuous ultrafiltration(SCUF).CVVH is the most commonly used model,usually as an adjuvant method for refractory heart failure,severe acute pancreatitis,rhabdomyolysis,and many others;CVVHDF has been widely used for the treatment of sepsis;HVHF is a treatment often for severe sepsis and septic shock;CPFA can be used in severe inflammatory response syndrome and sepsis;SCUF is often used in patients with refractory heart failure,edema,and overload of extracellular fluid volume.Every CRRT technology has its own characteristics,and the selection of therapeutic model and dosage must be individualized based on clinical situation of the patient.
分 类 号:R318.16[医药卫生—生物医学工程]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7